Epileptogenicity has been characterized by down-regulation of HIF-1α/hypoxia gene sets and STAT5b target genes, and CEBP-β and EMT signaling-associated gene sets, the latter is indicative of GBM progression potential [81]. This evidence concerns the gene HIF1A and glioblastoma.